Article
A systematic review and meta-analysis of MTHFR polymorphisms in methotrexate toxicity prediction in pediatric acute lymphoblastic leukemia.
The pharmacogenomics journal - 1 Dec 2013
Lopez-Lopez E, Martin-Guerrero I, Ballesteros J, Garcia-Orad A
Abstract excerpt
Methotrexate (MTX) is an important component of therapy used to treat childhood acute lymphoblastic leukemia (ALL). Two single-nucleotide polymorphisms (SNPs) in the methylenetetrahydrofolate reductase (MTHFR) gene, C677T and A1298C, affect MTHFR activity. A large body of studies has investigated the potential role of MTHFR SNPs in MTX toxicity in pediatric ALL. However, the results are controversial. In this...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
